These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enzymatic uricolysis: a study of the effect of a fungal urate-oxydase. Brogard JM; Coumaros D; Franckhauser J; Stahl A; Stahl J Rev Eur Etud Clin Biol; 1972 Nov; 17(9):890-5. PubMed ID: 4631795 [No Abstract] [Full Text] [Related]
6. [Clinical experience with a new uricolytic agent]. Alessandri C; Violi F; Bonavita MS Recenti Prog Med; 1986 Mar; 77(3):147-8. PubMed ID: 3715181 [No Abstract] [Full Text] [Related]
7. [Data on changes in blood and urinary uric acid induced by a urate oxidase]. Villiaumey J; Larget-Piet B; Rotterdam M Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):138-40. PubMed ID: 4563394 [No Abstract] [Full Text] [Related]
8. [Treatment of hyperuricemias in hematology using urate oxidase and allopurinol]. Zittoun R; Dauchy F; Teillaud C; Barthélémy M; Bouchard P Ann Med Interne (Paris); 1976; 127(6-7):479-82. PubMed ID: 970811 [No Abstract] [Full Text] [Related]
9. [Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin]. Brogard JM; Frankhauser J; Stahl A Schweiz Med Wochenschr; 1973 Mar; 103(11):404-10. PubMed ID: 4691800 [No Abstract] [Full Text] [Related]
10. Clinical quiz. A patient with hyperuricemia and renal failure. Williams T; Stine KC; Walker PD; Ilyas M; Wang Y; Blaszak RT Pediatr Nephrol; 2007 Jul; 22(7):948-53. PubMed ID: 17384967 [No Abstract] [Full Text] [Related]
11. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)]. Vigo P; Ortolani S; Soldati L; Girardello R; Fleischmann L; Polli EE Haematologica; 1981 Oct; 66(5):656-66. PubMed ID: 6796473 [No Abstract] [Full Text] [Related]
12. [Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase]. Oberling F; Lang JM Nouv Presse Med; 1974 Sep; 3(32):2026. PubMed ID: 4530260 [No Abstract] [Full Text] [Related]
13. Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome. Jankovic M; Zurlo MG; Rossi E; Edefonti A; Cossu MM; Giani M; Masera G Am J Pediatr Hematol Oncol; 1985; 7(2):202-4. PubMed ID: 3870345 [No Abstract] [Full Text] [Related]
14. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor. Krakoff IH; Murphy ML Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486 [No Abstract] [Full Text] [Related]
15. [Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology]. Zittoun R; Dauchy F; Teillaud C; Barthelemy M; Bouchard P Nouv Presse Med; 1976 Jan; 5(2):91. PubMed ID: 772604 [No Abstract] [Full Text] [Related]
16. [New trend in gout treatment. Clinical and biological study of urate oxidase]. Mizon JP; Plaquet R; Gentit F; Quiret JC Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000 [No Abstract] [Full Text] [Related]
17. [Physiopathology and treatment of hyperuricemia and gout]. Louyot P; Pourel J; Gaucher A; Montet Y Rein Foie; 1971; 13():103-27. PubMed ID: 5147550 [No Abstract] [Full Text] [Related]
18. Clinical disorders of uric acid metabolism. Beck LH Med Clin North Am; 1981 Mar; 65(2):401-11. PubMed ID: 6894473 [No Abstract] [Full Text] [Related]
19. Tumor lysis syndrome and neuroblastoma. Milano GM; De Sio L; Cozza R; Donfrancesco A Med Pediatr Oncol; 2003 Dec; 41(6):592. PubMed ID: 14595729 [No Abstract] [Full Text] [Related]
20. [Technic of determination of serum allantoin and study of the action of uricase]. Stahl A; Schang AM; Brogard JM; Coumaros C Ann Biol Clin (Paris); 1970; 28(5):377-85. PubMed ID: 5511721 [No Abstract] [Full Text] [Related] [Next] [New Search]